Follow this preprint

Safety, Pharmacokinetics, Biomarker Response, and Efficacy of E6742, a Dual Antagonist of Toll-Like Receptors 7 and 8, in a First-in-Patient, Randomized, Double-Blind, Phase 1/2 Study in Systemic Lupus Erythematosus

Yoshiya Tanaka, Atsushi Kumanogoh, Tatsuya Atsumi, Tomonori Ishii, Fumitoshi Tago, Mari Aoki, Shintaro Yamamuro, Shizuo Akira
doi: https://doi.org/10.1101/2024.04.26.24306410
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article Information

doi 
https://doi.org/10.1101/2024.04.26.24306410
History 
  • April 27, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Yoshiya Tanaka1,*,
  2. Atsushi Kumanogoh2,
  3. Tatsuya Atsumi3,
  4. Tomonori Ishii4,
  5. Fumitoshi Tago5,
  6. Mari Aoki5,
  7. Shintaro Yamamuro5 and
  8. Shizuo Akira6
  1. 1University of Occupational and Environmental Health, Japan, Kitakyushu, Japan
  2. 2Department of Respiratory Medicine and Clinical Immunology, Osaka University Faculty of Medicine Graduate School of Medicine, Osaka, Japan
  3. 3Department of Rheumatology, Endocrinology, and Nephrology, Hokkaido University, Sapporo, Japan
  4. 4Department of Hematology and Rheumatology, Tohoku University Hospital, Miyagi, Japan
  5. 5Eisai Co., Ltd., Tokyo, Japan
  6. 6Department of Host Defense, Osaka University Immunology Frontier Research Center, Osaka, Japan
  1. ↵*Corresponding author: Yoshiya Tanaka, First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, 1-1 Iseigaoka, Yahata-nishi, Kitakyushu, Fukuoka 807-8555, Japan. Tel.: +81-93-603-1611; Fax. +81-93-691-9334; E-mail: tanaka{at}med.uoeh-u.ac.jp
Back to top
Posted April 27, 2024.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML

Supplementary Material

Data/Code
Email
Safety, Pharmacokinetics, Biomarker Response, and Efficacy of E6742, a Dual Antagonist of Toll-Like Receptors 7 and 8, in a First-in-Patient, Randomized, Double-Blind, Phase 1/2 Study in Systemic Lupus Erythematosus
Yoshiya Tanaka, Atsushi Kumanogoh, Tatsuya Atsumi, Tomonori Ishii, Fumitoshi Tago, Mari Aoki, Shintaro Yamamuro, Shizuo Akira
medRxiv 2024.04.26.24306410; doi: https://doi.org/10.1101/2024.04.26.24306410
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

1

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.